Related Experiment Video
Updated: Jul 5, 2026
Method to Visualize and Analyze Membrane Interacting Proteins by Transmission Electron Microscopy
Published on: March 5, 2017
Regulate PD-L1's membrane orientation thermodynamics with hydrophobic nanoparticles
Xiaoqian Lin1,2,3, Xubo Lin1
1Beijing Advanced Innovation Center for Biomedical Engineering, Key Laboratory of Ministry of Education for Biomechanics and Mechanobiology, School of Engineering Medicine & School of Biological Science and Medical Engineering, Beihang University, Beijing 100191, China. linxbseu@buaa.edu.cn.
Hydrophobic nanoparticles alter the membrane orientation of PD-L1, enhancing T cell engagement for cancer immunotherapy. This nanomedicine approach offers a novel strategy beyond traditional PD-L1/PD-1 blocking therapies.
Area of Science:
- Biophysics
- Immunology
- Nanomedicine
Background:
- Tumor cells evade immune detection via the PD-L1/PD-1 pathway.
- Targeting PD-L1 or PD-1 is a key strategy in cancer immunotherapy.
- Current therapies focus on blocking the PD-L1/PD-1 binding interface.
Purpose of the Study:
- To investigate nanoparticle-mediated regulation of PD-L1 membrane orientation.
- To explore an alternative nanomedicine strategy for PD-L1-related immunotherapy.
Main Methods:
- Utilized microsecond-scale coarse-grained molecular dynamics (MD) simulations.
- Simulated ligand-modified ultra-small hydrophobic nanoparticles (NPs).
- Analyzed the effect of NPs on PD-L1's extracellular and transmembrane domains.
Main Results:
- Embedded hydrophobic NPs enhance the "stand up" state probability of PD-L1's extracellular domain.
- Hydrophobic NPs promote tilting of PD-L1's transmembrane domain.
- Ligand length and NP concentration influence these effects.
Conclusions:
- Nanoparticle interaction with PD-L1 offers a novel immunotherapy strategy.
- This approach modulates PD-L1 thermodynamics for improved T cell interaction.
- Findings suggest a new nanomedicine avenue for cancer treatment.
